Bandfor>whic Do not take this medication at the doses it contains: Consult your doctor or pharmacist before starting to take Vitagobens. Interference with diagnostic tests If you are to undergo any diagnostic test (including blood, urine, skin tests using allergens, etc.), inform your doctor that you are taking this medication, as it may alter the results. In some determinations of urobilinogen, theophylline, uric acid, or antibodies against intrinsic factor (FI), false results may be produced. This medication is contraindicated in children under 14 years old. Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This medication may interact with the following medications: Excessive alcohol consumption reduces the absorption of vitamins. If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication. Due to the high doses of vitamins B contained in Vitagobens, which are much higher than those recommended during pregnancy and lactation, this medication is contraindicated during pregnancy and lactation. Vitagobens is not recommended for women of childbearing age who do not use an effective contraceptive method. No effects of the product on the ability to drive or operate machinery have been reported. However, this medication may cause drowsiness in a few patients, who should not drive and/or operate hazardous machinery during treatment. This medication contains red Ponceau 4R (E-124). It may cause allergic reactions. This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".Do not take Vitagobens
Warnings and precautions
Children
Other medications and Vitagobens
Taking Vitagobens with alcohol
Pregnancy, lactation, and fertility
Driving and operating machinery
Vitagobens contains red Ponceau 4R (E-124) and sodium
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults and adolescents over 14 years:1 tablet per day.
Generally, treatment should not exceed 15 days in duration, although your doctor may recommend administration for a longer period.
If symptoms worsen or do not improve after 7 days of treatment, you must consult your doctor.
Oral administration.
It is preferable to swallow the tablets whole, with the help of a sufficient amount of water.
Patients with liver or kidney insufficiency
These patients should not take Vitagobens (see section 2).
If you have taken more Vitagobens than you should, you may experience symptoms such as: gastrointestinal discomfort (diarrhea, nausea, vomiting) and headache. Due to the content of pyridoxine, you may suffer from nervous system disorders such as alterations or reduction of sensitivity, paresthesia, numbness in feet and hands, unstable gait, etc.; you may also experience sun sensitivity with skin eruptions; drowsiness, lethargy, respiratory difficulty, among other effects, depending on the dose, increase in serum AST (SGOT) concentrations (a transaminase) and decrease in serum folate concentrations. In rare cases, a severe allergic reaction (anaphylactic shock) may occur.
In children, accidental ingestion of very high doses of vitamin B6may produce, in addition, deep sedation, weakness, and respiratory difficulty.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center or call the Toxicological Information Service, phone: 915 62 04 20, indicating the medication and the amount taken.
Do not take a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not everyone will experience them.
The assessment of adverse effects that may occur is based on the following frequencies: very frequent (may affect more than 1 in 10 people), frequent (may affect up to 1 in 10 people), infrequent (may affect up to 1 in 100 people), rare (may affect up to 1 in 1,000 people), and very rare (may affect up to 1 in 10,000 people), unknown frequency (cannot be estimated from available data).
Infrequently, the following may appear: nausea, vomiting, headache, drowsiness, paresthesias (tingling sensation in arms and legs) and skin rash (redness or swelling). Reactions of hypersensitivity (allergic reactions) to vitamins B1, B6, and B12have also been described.
Other adverse effects that have been reported, with unknown frequency, are: digestive discomfort, diarrhea, loss of appetite with high doses, photosensitivity with skin lesions such as blisters, redness, itching; very occasionally, a reduction in the number of platelets (thrombocytopenia); insomnia; disorder with reduced sensitivity and tingling, among other symptoms, which generally decrease when treatment is interrupted; worsening of Leber's disease (hereditary disease that causes loss of vision); changes in urine color, which usually disappear in 48 hours; occasionally, anaphylactic reaction with itching, sweating, difficulty breathing, increased heart rate, etc. Repeated administration of vitamin B1may cause relapses in skin allergic reactions in people allergic to this vitamin.
If an allergic reaction occurs, treatment should be interrupted and a doctor should be consulted immediately to apply appropriate treatment.
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packaging and unused medications. By doing so, you will help protect the environment.
Composition of Vitagobens
Each tablet contains 250 mg of thiamine hydrochloride, 250 mg of pyridoxine hydrochloride and 500 micrograms of cyanocobalamin.
Core : pregelatinized cornstarch, anhydrous citric acid, sodium citrate dihydrate, colloidal silica, copovidone, sodium glycolate from potato type A and sodium stearoyl fumarate.
Covering : hypromellose, titanium dioxide (E171), glycerol, propylene glycol dicaprylate, red food color Ponceau 4R (E124) and carnauba wax.
This medicine is presented in the form of coated tablets with a pink film, elliptical and biconvex.
Packaging of 30 tablets.
Normon Laboratories, S.A.
Ronda de Valdecarrizo, 6
28760 – Tres Cantos
Madrid (Spain)
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.